O. Vérier‐Mine

850 total citations
18 papers, 396 citations indexed

About

O. Vérier‐Mine is a scholar working on Obstetrics and Gynecology, Endocrinology, Diabetes and Metabolism and General Health Professions. According to data from OpenAlex, O. Vérier‐Mine has authored 18 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Obstetrics and Gynecology, 6 papers in Endocrinology, Diabetes and Metabolism and 4 papers in General Health Professions. Recurrent topics in O. Vérier‐Mine's work include Gestational Diabetes Research and Management (10 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Birth, Development, and Health (4 papers). O. Vérier‐Mine is often cited by papers focused on Gestational Diabetes Research and Management (10 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Birth, Development, and Health (4 papers). O. Vérier‐Mine collaborates with scholars based in France, Switzerland and United Kingdom. O. Vérier‐Mine's co-authors include P. Fontaine, A. Vambergue, M C Nuttens, David J. Webb, Nish Chaturvedi, J. H. Fuller, Chrystel Leroy, Asma Chaoui, Véronique Pingault and Séverine Marcos and has published in prestigious journals such as The American Journal of Human Genetics, Diabetic Medicine and Diabetes Obesity and Metabolism.

In The Last Decade

O. Vérier‐Mine

16 papers receiving 381 citations

Peers

O. Vérier‐Mine
Fabien Guimiot France
Andrea Guerin Canada
Arti Patel United States
Rebecca Jackson United States
Mostafa Maged Ali Egypt
Katsuji Matsuzawa Japan
Brian L. Cohen United States
J Jirásek Czechia
Fabien Guimiot France
O. Vérier‐Mine
Citations per year, relative to O. Vérier‐Mine O. Vérier‐Mine (= 1×) peers Fabien Guimiot

Countries citing papers authored by O. Vérier‐Mine

Since Specialization
Citations

This map shows the geographic impact of O. Vérier‐Mine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Vérier‐Mine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Vérier‐Mine more than expected).

Fields of papers citing papers by O. Vérier‐Mine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Vérier‐Mine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Vérier‐Mine. The network helps show where O. Vérier‐Mine may publish in the future.

Co-authorship network of co-authors of O. Vérier‐Mine

This figure shows the co-authorship network connecting the top 25 collaborators of O. Vérier‐Mine. A scholar is included among the top collaborators of O. Vérier‐Mine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Vérier‐Mine. O. Vérier‐Mine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Meyer, Laurent, Thierry Hannedouche, Kristian Kunz, et al.. (2020). Effect of adding vildagliptin to insulin in haemodialysed patients with type 2 diabetes: The VILDDIAL study, a randomized, multicentre, prospective study. Diabetes Obesity and Metabolism. 22(6). 978–987. 8 indexed citations
2.
Gautier, Jean–François, O. Vérier‐Mine, Paul Valensi, et al.. (2016). Which oral antidiabetic drug to combine with metformin to minimize the risk of hypoglycemia when initiating basal insulin?. Diabetes Research and Clinical Practice. 116. 26–28. 3 indexed citations
3.
4.
Pingault, Véronique, Viviane Baral, Séverine Marcos, et al.. (2013). Loss-of-Function Mutations in SOX10 Cause Kallmann Syndrome with Deafness. The American Journal of Human Genetics. 92(5). 707–724. 142 indexed citations
5.
6.
Dumont, Aaron S., et al.. (2011). P246 - Analyses des pratiques contraceptives dans une cohorte de patientes consultant pour chirurgie bariatrique. Diabetes & Metabolism. 37(1). A91–A91.
7.
Vérier‐Mine, O.. (2010). Devenir maternel après un diabète gestationnel. Dépistage et prévention du diabète de type 2. Revue de la littérature. Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément. 39(8). S299–S321. 2 indexed citations
8.
Vérier‐Mine, O.. (2010). Outcomes in women with a history of gestational diabetes. Screening and prevention of type 2 diabetes. Literature review. Diabetes & Metabolism. 36(6). 595–616. 59 indexed citations
9.
10.
11.
Vérier‐Mine, O.. (2009). L’étude HAPO : les commentaires d’une diabétologue. Médecine des Maladies Métaboliques. 3(1). 80–83. 1 indexed citations
12.
Odou, Marie‐Françoise, Catherine Cardot-Bauters, Marie‐Christine Vantyghem, et al.. (2006). Contribution of genetic analysis in screening for MEN1 among patients with sporadic disease and one or more typical manifestation. Annales d Endocrinologie. 67(6). 581–587. 8 indexed citations
13.
Vérier‐Mine, O., et al.. (2005). Is pregnancy a risk factor for microvascular complications?. UCL Discovery (University College London). 1 indexed citations
14.
Vérier‐Mine, O., et al.. (2005). Is pregnancy a risk factor for microvascular complications? The EURODIAB Prospective Complications Study. Diabetic Medicine. 22(11). 1503–1509. 38 indexed citations
15.
Romon, Monique, M C Nuttens, A. Vambergue, et al.. (2001). Higher Carbohydrate Intake is Associated with Decreased Incidence of Newborn Macrosomia in Women with Gestational Diabetes. Journal of the American Dietetic Association. 101(8). 897–902. 40 indexed citations
16.
Vambergue, A., et al.. (2000). Is mild gestational hyperglycaemia associated with maternal and neonatal complications? The Diagest Study. Diabetic Medicine. 17(3). 203–208. 71 indexed citations
17.
Vambergue, A., Isabelle Fajardy, Murielle Cazaubiel, et al.. (1997). GESTATIONAL DIABETES MELLITUS AND HLA CLASS II (‐DQ, ‐DR) ASSOCIATION: THE DIAGEST STUDY. European Journal of Immunogenetics. 24(5). 385–394. 17 indexed citations
18.
Vérier‐Mine, O. & José Timsit. (1997). [What are the different modalities for the therapeutic management of gestational diabetes?].. PubMed. 23 Suppl 5. 30–3. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fabien Guimiot Breakdown of academic impact, for papers by Andrea Guerin Breakdown of academic impact, for papers by Arti Patel Breakdown of academic impact, for papers by Rebecca Jackson Breakdown of academic impact, for papers by Mostafa Maged Ali Breakdown of academic impact, for papers by Katsuji Matsuzawa Breakdown of academic impact, for papers by Brian L. Cohen Breakdown of academic impact, for papers by J Jirásek
Rankless by CCL
2026